ZIMMER BIOMET HOLDINGS, INC. (ZBH)
ZIMMER BIOMET HOLDINGS, INC. (ZBH) from its SEC filings: 2025 revenue $8.2 billion (+7% vs the year before), net margin 9%, free cash flow $1.5 billion. Insider trades, recent filings and a price chart. Free.
| Exchange | NYSE |
| Industry | Orthopedic, Prosthetic & Surgical Appliances & Supplies |
| Revenue (2025) | $8.2 billion |
| Revenue growth | +7% |
| Net income | $705.1 million |
| Net margin | 8.6% |
| Free cash flow | $1.5 billion |
| Diluted EPS | $3.55 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +5% |
| Cash | $410.0 million |
| Long-term debt | $6.3 billion |
| Share count, 1 year | -4% |
| Fundamentals check | Mixed fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.